Aurora Cannabis (TSE:ACB) Stock Price Up 0.8% - What's Next?

Key Points

• Aurora Cannabis shares rose 0.8% to C$5.08 (intraday high C$5.15) on Monday, with ~431,950 shares traded — a 17% increase versus average volume.
• Analysts are generally bullish: the consensus rating is Buy with a consensus price target of C$9.25, and Canaccord Genuity set a C$10.00 target with a Buy rating.
• Fundamentals remain strained — market cap C$300.4M, negative net margin and ROE, and last quarter EPS of C$0.03. Analysts expect -0.22 EPS for the fiscal year and the stock trades below its 200‑day moving average (C$5.88).

Aurora Cannabis Inc. (TSE:ACB - Get Free Report)'s share price rose 0.8% during mid-day trading on Monday . The stock traded as high as C$5.15 and last traded at C$5.08. Approximately 431,950 shares were traded during trading, an increase of 17% from the average daily volume of 368,761 shares. The stock had previously closed at C$5.04.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group set a C$10.00 price target on shares of Aurora Cannabis and gave the stock a "buy" rating in a research note on Tuesday, January 27th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of C$9.25.

Aurora Cannabis Price Performance

The company has a market capitalization of C$300.37 million, a price-to-earnings ratio of -3.39 and a beta of 0.40. The company's 50 day simple moving average is C$4.83 and its 200-day simple moving average is C$5.88. The company has a current ratio of 3.06, a quick ratio of 2.48 and a debt-to-equity ratio of 25.02.

Aurora Cannabis (TSE:ACB - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported C$0.03 earnings per share (EPS) for the quarter. Aurora Cannabis had a negative net margin of 1.69% and a negative return on equity of 1.15%. The company had revenue of C$94.19 million for the quarter. On average, equities research analysts predict that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.